These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 27321245)

  • 1. Long-term right ventricular implantable cardioverter-defibrillator lead performance in arrhythmogenic right ventricular cardiomyopathy.
    Herman AR; Gardner M; Steinberg C; Yeung-Lai-Wah JA; Healey JS; Leong-Sit P; Krahn AD; Chakrabarti S
    Heart Rhythm; 2016 Oct; 13(10):1964-70. PubMed ID: 27321245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Performance of Right Ventricular Implantable Cardioverter-Defibrillator Leads in Arrhythmogenic Right Ventricular Cardiomyopathy and Hypertrophic Cardiomyopathy.
    Sagawa Y; Nagata Y; Yamaguchi T; Mitsui K; Nagamine T; Yamaguchi J; Hijikata S; Watanabe K; Masuda R; Miyazaki R; Kaneko M; Miwa N; Sekigawa M; Hara N; Nozato T; Ashikaga T; Goya M; Sasano T; Hirao K
    Int Heart J; 2020 Jan; 61(1):39-45. PubMed ID: 31956141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients.
    Wichter T; Paul M; Wollmann C; Acil T; Gerdes P; Ashraf O; Tjan TD; Soeparwata R; Block M; Borggrefe M; Scheld HH; Breithardt G; Böcker D
    Circulation; 2004 Mar; 109(12):1503-8. PubMed ID: 15007002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular cardiomyopathy: the course of electronic parameters, clinical features, and complications during long-term follow-up.
    Mugnai G; Tomei R; Dugo C; Tomasi L; Morani G; Vassanelli C
    J Interv Card Electrophysiol; 2014 Oct; 41(1):23-9. PubMed ID: 24928487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LEFT VENTRICULAR LEAD PLACEMENT FOR PACING AND SENSING IN A PATIENT WITH ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY UNDERGOING ICD IMPLANTATION.
    Taleski J; Manola Š; Radeljić V; Bulj N; Delić Brkljačić D; Pavlović N
    Acta Clin Croat; 2019 Jun; 58(2):391-393. PubMed ID: 31819339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arrhythmogenic right ventricular cardiomyopathy/dysplasia in Saudi Arabia: a single-center experience with long-term follow-up.
    Al-Ghamdi B; Shafquat A; Mallawi Y
    Ann Saudi Med; 2014; 34(5):415-26. PubMed ID: 25827699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular sensing and pacing for sensing difficulties in internal cardioverter defibrillator therapy for arrhythmogenic right ventricular cardiomyopathy.
    Lochy S; François B; Hollanders G; Provenier F
    Europace; 2010 Aug; 12(8):1195-6. PubMed ID: 20348554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of cardioverter-defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy.
    Boriani G; Artale P; Biffi M; Martignani C; Frabetti L; Valzania C; Diemberger I; Ziacchi M; Bertini M; Rapezzi C; Parlapiano M; Branzi A
    Heart Vessels; 2007 May; 22(3):184-92. PubMed ID: 17533523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of arrhythmogenic right ventricular cardiomyopathy patients with an implantable cardioverter-defibrillator for prevention of sudden cardiac death.
    Yin K; Ding L; Li Y; Hua W
    Clin Cardiol; 2017 Apr; 40(4):216-221. PubMed ID: 28139837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous Implantable Cardioverter-Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Transatlantic Experience.
    Orgeron GM; Bhonsale A; Migliore F; James CA; Tichnell C; Murray B; Bertaglia E; Cadrin-Tourigny J; De Franceschi P; Crosson J; Tandri H; Corrado D; Calkins H
    J Am Heart Assoc; 2018 Nov; 7(21):e008782. PubMed ID: 30608223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Right ventricular function is a predictor for sustained ventricular tachycardia requiring anti-tachycardic pacing in arrhythmogenic ventricular cardiomyopathy: insight into transvenous vs. subcutaneous implantable cardioverter defibrillator insertion.
    Honarbakhsh S; Protonotarios A; Monkhouse C; Hunter RJ; Elliott PM; Lambiase PD
    Europace; 2023 May; 25(5):. PubMed ID: 37213071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy.
    Hodgkinson KA; Howes AJ; Boland P; Shen XS; Stuckless S; Young TL; Curtis F; Collier A; Parfrey PS; Connors SP
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):. PubMed ID: 26966288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease in amplitude of intracardiac ventricular electrogram and inappropriate therapy in patients with an implantable cardioverter defibrillator.
    Watanabe H; Chinushi M; Izumi D; Sato A; Okada S; Okamura K; Komura S; Hosaka Y; Furushima H; Washizuka T; Aizawa Y
    Int Heart J; 2006 May; 47(3):363-70. PubMed ID: 16823242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcutaneous implantable cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy: Results from an Italian multicenter registry.
    Migliore F; Viani S; Bongiorni MG; Zorzi A; Silvetti MS; Francia P; D'Onofrio A; De Franceschi P; Sala S; Donzelli S; Ricciardi G; Menardi E; Giammaria M; La Greca C; Bauce B; Rigato I; Iliceto S; Bertaglia E; Diemberger I; Corrado D
    Int J Cardiol; 2019 Apr; 280():74-79. PubMed ID: 30661851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of mid-septal electrode placement in implantable cardioverter defibrillator recipients--results of the SPICE (Septal Positioning of ventricular ICD Electrodes) study.
    Kolb C; Solzbach U; Biermann J; Semmler V; Kloppe A; Klein N; Lennerz C; Szendey I; Andrikopoulos G; Tzeis S; Asbach S;
    Int J Cardiol; 2014 Jul; 174(3):713-20. PubMed ID: 24838056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additional left ventricular septal lead facilitates R-wave sensing of implantable cardioverter-defibrillator in arrhythmogenic right ventricular cardiomyopathy: a case report.
    Lu W; Chen K; Dai Y; Zhang S
    Eur Heart J Case Rep; 2023 Jan; 7(1):ytac491. PubMed ID: 36685095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
    Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy.
    Calkins H; Corrado D; Marcus F
    Circulation; 2017 Nov; 136(21):2068-2082. PubMed ID: 29158215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized study of defibrillator lead implantations in the right ventricular mid-septum versus the apex: the SEPTAL study.
    Mabo P; Defaye P; Mouton E; Cebron JP; Davy JM; Tassin A; Babuty D; Mondoly P; Paziaud O; Anselme F; Daubert JC
    J Cardiovasc Electrophysiol; 2012 Aug; 23(8):853-60. PubMed ID: 22452288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional electroanatomic voltage mapping increases accuracy of diagnosing arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Corrado D; Basso C; Leoni L; Tokajuk B; Bauce B; Frigo G; Tarantini G; Napodano M; Turrini P; Ramondo A; Daliento L; Nava A; Buja G; Iliceto S; Thiene G
    Circulation; 2005 Jun; 111(23):3042-50. PubMed ID: 15939822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.